New study tests if early drug use can stop psoriasis from becoming chronic

NCT ID NCT06742333

Recruiting now Disease control Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether early use of the drug bimekizumab can delay or prevent chronic inflammation in people with mild plaque psoriasis. 40 adults with recent-onset or long-standing mild psoriasis will receive either bimekizumab injections or a topical steroid cream. The goal is to see if bimekizumab can keep the disease from becoming a long-term problem.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSORIASIS

Contacts and locations

Locations

CHITS
RECRUITING

Toulon, 83000, France
CHU Saint-Etienne
RECRUITING

Saint-Etienne, 42055, France
CHU de Nice - Hôpital de l'Archet
RECRUITING

Nice, Alpes-Maritimes, 06200, France
Cabinet Dermatologie Dr RUER
RECRUITING

Martigues, 13500, France
Hôpital Edouard Herriot
RECRUITING

Lyon, 69003, France
Hôpital Saint-Joseph
RECRUITING

Marseille, 13005, France
Médipole Villeurbanne
ENROLLING_BY_INVITATION

Villeurbanne, 69100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.